-
1
-
-
33751039773
-
Detection and treatment of depressive and anxiety disorders among cancer patients: Feasibility and preliminary findings from a liaison service in an oncology division
-
DOI 10.1002/da.20198
-
Pasquini M, Biondi M, Costantini A, Cairoli F, Ferrarese G, Picardi A, Sternberg C: Detection and treatment of depressive and anxiety disorders among cancer patients: Feasibility and preliminar findings from a Liason Service in an Oncology division. Depress Anxiety 2006; 23: 441-448. (Pubitemid 44757154)
-
(2006)
Depression and Anxiety
, vol.23
, Issue.7
, pp. 441-448
-
-
Pasquini, M.1
Biondi, M.2
Costantini, A.3
Cairoli, F.4
Ferrarese, G.5
Picardi, A.6
Sternberg, C.7
-
2
-
-
84155166834
-
Pharmacotherapy of depression in people with cancer
-
in Kissane DW, Maj M, Sartorius N (eds) Chichester, Wiley
-
Grassi L, Nanni MG, Uchitomi Y, Riba M, Kissane DW, Maj M, Sartorius N: Pharmacotherapy of depression in people with cancer; in Kissane DW, Maj M, Sartorius N (eds): Depression and Cancer. Chichester, Wiley, 2010.
-
(2010)
Depression and Cancer
-
-
Grassi, L.1
Nanni, M.G.2
Uchitomi, Y.3
Riba, M.4
Kissane, D.W.5
Maj, M.6
Sartorius, N.7
-
3
-
-
84855421054
-
-
São Paulo Summus Editorial
-
Carvalho VA, Macieira RC, Liberato RP, Veit MT, Kovács MJ, Gomes MJB, et al: Temas em psico-oncologia. São Paulo, Summus Editorial, 2008.
-
(2008)
Temas Em Psico-Oncologia
-
-
Carvalho, V.A.1
Macieira, R.C.2
Liberato, R.P.3
Veit, M.T.4
Kovács, M.J.5
Gomes, M.J.B.6
-
4
-
-
12344305375
-
Prevalence of depression in patients with cancer
-
Massie MJ: Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 2004; 32: 57-71.
-
(2004)
J Natl Cancer Inst Monogr
, vol.32
, pp. 57-71
-
-
Massie, M.J.1
-
5
-
-
34547968264
-
Psychiatric concomitants of cancer, screening procedures, and training of health care professionals in oncology: The paradigms of psycho-oncology in the psychiatry field
-
in Christodoulou GN (ed) Athens, Beta Publishing Athens
-
Grassi L, Holland JC, Johansen C, Koch U, Fawzy F: Psychiatric concomitants of cancer, screening procedures, and training of health care professionals in oncology: The paradigms of psycho-oncology in the psychiatry field; in Christodoulou GN (ed): Advances in Psychiatry. Athens, Beta Publishing Athens, 2005.
-
(2005)
Advances in Psychiatry
-
-
Grassi, L.1
Holland, J.C.2
Johansen, C.3
Koch, U.4
Fawzy, F.5
-
6
-
-
0037218812
-
Depression as a prognostic factor for breast cancer mortality
-
Hjerl K, Andersen EW, Keiding N, Mouridsen HT, Mortensen PB, Jorgensen T: Depression as a prognostic factor for breast cancer mortality. Psychosomatics 2003; 44: 24-33.
-
(2003)
Psychosomatics
, vol.44
, pp. 24-33
-
-
Hjerl, K.1
Andersen, E.W.2
Keiding, N.3
Mouridsen, H.T.4
Mortensen, P.B.5
Jorgensen, T.6
-
7
-
-
0037094076
-
Depression and functional status as predictors of death among cancer patients
-
DOI 10.1002/cncr.10533
-
Stommel M, Given BA, Given CW: Depression and functional status as predictors of death among cancer patients. Cancer 2002; 94: 2719-2727. (Pubitemid 34478089)
-
(2002)
Cancer
, vol.94
, Issue.10
, pp. 2719-2727
-
-
Stommel, M.1
Given, B.A.2
Given, C.W.3
-
8
-
-
39549088291
-
Clinical experience of the use of a pharmacological treatment algorithm for major depressive disorder in patients with advanced cancer
-
DOI 10.1002/pon.1213
-
Okamura M, Akizuki N, Nakano T, Shimizu K, Ito T, Akechi T, Uchitomi Y: Clinical experience of the use of a pharmacological treatment algorithm for major depressive disorder in patients with advanced cancer. Psychooncology 2008; 17: 154-160. (Pubitemid 351279866)
-
(2008)
Psycho-Oncology
, vol.17
, Issue.2
, pp. 154-160
-
-
Okamura, M.1
Akizuki, N.2
Nakano, T.3
Shimizu, K.4
Ito, T.5
Akechi, T.6
Uchitomi, Y.7
-
9
-
-
79251502239
-
The management of depression in palliative care
-
Rayner L, Rayner L, Price A, Hotopf M, Higginson IJ: The management of depression in palliative care. Eur J Cancer Care 2011; 47: 702-712.
-
(2011)
Eur J Cancer Care
, vol.47
, pp. 702-712
-
-
Rayner, L.1
Rayner, L.2
Price, A.3
Hotopf, M.4
Higginson, I.J.5
-
10
-
-
0025015295
-
Changes in the prescription patterns of psychotropic drugs for cancer patients during a 10-year period
-
Stiefel FC, Komblith AB, Holland JC: Changes in prescription patterns of psychotropic drugs for cancer patients during a 10-year period. Cancer 1990; 65: 1048-1053. (Pubitemid 20063514)
-
(1990)
Cancer
, vol.65
, Issue.4
, pp. 1048-1053
-
-
Stiefel, F.C.1
Kornblith, A.B.2
Holland, J.C.3
-
11
-
-
36549071810
-
Treatment of depression in cancer patients
-
Rodin G, Katz M, Lloyd N, Green E, Mackay JA, Wong RK: Treatment of depression in cancer patients. Curr Oncol 2007; 14: 180-188.
-
(2007)
Curr Oncol
, vol.14
, pp. 180-188
-
-
Rodin, G.1
Katz, M.2
Lloyd, N.3
Green, E.4
Mackay, J.A.5
Wong, R.K.6
-
12
-
-
0031597103
-
Psychotropic drug metabolism in cancer patients: Clinical aspects of management of potential drug interactions
-
Kalash GR: Psychotropic drug metabolism in cancer patients: Clinical aspects of management of potential drug interactions. Psychooncology 1998; 7: 307-320.
-
(1998)
Psychooncology
, vol.7
, pp. 307-320
-
-
Kalash, G.R.1
-
13
-
-
84984535800
-
Harnessing the internet cloud for managing drug interactions with chemotherapy regimens in patients with cancer suffering from depression
-
Yap KY, Ho YX, Chui WK, Chan A: Harnessing the internet cloud for managing drug interactions with chemotherapy regimens in patients with cancer suffering from depression. Acta Oncol 2010; 49: 1235-1245.
-
(2010)
Acta Oncol
, vol.49
, pp. 1235-1245
-
-
Yap, K.Y.1
Ho, Y.X.2
Chui, W.K.3
Chan, A.4
-
14
-
-
0004717723
-
-
ed 3. Philadelphia, Lippincott Williams &Wilkins
-
Ciraulo DA, Shader RI, Greenblatt DJ, Creelman WL: Drug Interactions in Psychiatry, ed 3. Philadelphia, Lippincott Williams &Wilkins, 2006.
-
(2006)
Drug Interactions in Psychiatry
-
-
Ciraulo, D.A.1
Shader, R.I.2
Greenblatt, D.J.3
Creelman, W.L.4
-
16
-
-
0030867948
-
Pharmacokinetic drug interactions of new antidepressants: A review of the effects on the metabolism of other drugs
-
Richelson E: Pharmacokinetic drug interactions of new antidepressants: A review of the effects on metabolism of other drugs. Mayo Clin Proc 1997; 72: 835-847. (Pubitemid 27382924)
-
(1997)
Mayo Clinic Proceedings
, vol.72
, Issue.9
, pp. 835-847
-
-
Richelson, E.1
-
17
-
-
33847109783
-
The pharmacological importance of cytochrome CYP3A4 in the palliation of symptoms: Review and recommendations for avoiding adverse drug interactions
-
DOI 10.1007/s00520-006-0127-5
-
Haddad A, Davis M, Lagman R: The pharmacological importance of cytochrome CYP3A4 in palliation of symptoms: Review and recommendations for avoiding adverse drug interactions. Support Care Cancer 2007; 15: 251-257. (Pubitemid 46295205)
-
(2007)
Supportive Care in Cancer
, vol.15
, Issue.3
, pp. 251-257
-
-
Haddad, A.1
Davis, M.2
Lagman, R.3
-
18
-
-
76649089656
-
Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: A population cohort study
-
Kelly MC, Juurlink DN, Gomes T, Duon- Hua M, Pritchard KI, Austin PC, Paszat LF: Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: A population cohort study. BMJ 2010; 340:c693.
-
(2010)
BMJ
, vol.340
-
-
Kelly, M.C.1
Juurlink, D.N.2
Gomes, T.3
Duon- Hua, M.4
Pritchard, K.I.5
Austin, P.C.6
Paszat, L.F.7
-
19
-
-
74549144558
-
Interactions between tamoxifen and antidepressants via cytochrome P450 2D6
-
Desmarais JE, Looper KJ: Interactions between tamoxifen and antidepressants via cytochrome P450 2D6. J Clin Psychiatry 2009; 70: 1688-1697.
-
(2009)
J Clin Psychiatry
, vol.70
, pp. 1688-1697
-
-
Desmarais, J.E.1
Looper, K.J.2
-
22
-
-
0037421590
-
Pharmacogenomics - Drug disposition, drug targets, and side effects
-
DOI 10.1056/NEJMra020526
-
Evans WE, McLeod HL: Pharmacogenomics - Drug disposition, drug targets, and side effects. N Engl J Med 2003; 348: 538-549. (Pubitemid 36159890)
-
(2003)
New England Journal of Medicine
, vol.348
, Issue.6
, pp. 538-549
-
-
Evans, W.E.1
McLeod, H.L.2
-
23
-
-
36349024762
-
Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes
-
DOI 10.1200/JCO.2007.12.2705
-
Schroth W, Antoniadou L, Fritz P, Schwab M, Muerdter T, Zanger UM, et al: Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes. J Clin Oncol 2007; 25: 5187-5193. (Pubitemid 350232249)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.33
, pp. 5187-5193
-
-
Schroth, W.1
Antoniadou, L.2
Fritz, P.3
Schwab, M.4
Muerdter, T.5
Zanger, U.M.6
Simon, W.7
Eichelbaum, M.8
Brauch, H.9
-
24
-
-
70349929431
-
Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen
-
Schroth W, Goetz MP, Hamann U, Fasching PA, Schmidt M, Winter S, et al: Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen. JAMA 2009; 302: 1429-1436.
-
(2009)
JAMA
, vol.302
, pp. 1429-1436
-
-
Schroth, W.1
Goetz, M.P.2
Hamann, U.3
Fasching, P.A.4
Schmidt, M.5
Winter, S.6
-
25
-
-
43649090742
-
Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy
-
DOI 10.1111/j.1349-7006.2008.00780.x
-
Kiyotani K, Mushiroda T, Sasa M, Bando Y, Sumitomo I, Hosono N, et al: Impact of CYP2D6 * 10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy. Cancer Sci 2008; 99: 995-999. (Pubitemid 351997603)
-
(2008)
Cancer Science
, vol.99
, Issue.5
, pp. 995-999
-
-
Kiyotani, K.1
Mushiroda, T.2
Sasa, M.3
Bando, Y.4
Sumitomo, I.5
Hosono, N.6
Kubo, M.7
Nakamura, Y.8
Zembutsu, H.9
-
26
-
-
47749105202
-
Association between CYP2D6 * 10 genotype and survival of breast cancer patients receiving tamoxifen treatment
-
Xun Y, Sun Y, Yao L, Shi L, Wu Y, Ouyang T, et al: Association between CYP2D6 * 10 genotype and survival of breast cancer patients receiving tamoxifen treatment. Ann Oncol 2008; 19: 1423-1429.
-
(2008)
Ann Oncol
, vol.19
, pp. 1423-1429
-
-
Xun, Y.1
Sun, Y.2
Yao, L.3
Shi, L.4
Wu, Y.5
Ouyang, T.6
-
27
-
-
19944434201
-
CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment
-
Jin Y, Desta Z, Stearns V, Ward B, Ho H, Lee KH, et al: CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. J Natl Cancer Inst 2005; 97: 30-39.
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 30-39
-
-
Jin, Y.1
Desta, Z.2
Stearns, V.3
Ward, B.4
Ho, H.5
Lee, K.H.6
-
28
-
-
33745347897
-
Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: Implication for optimization of breast cancer treatment
-
DOI 10.1016/j.clpt.2006.03.013, PII S0009923606001366
-
Borges S, Desta Z, Li L, Skaar TC, Ward BA, Nguyen A, et al: Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: Implication for optimization of breast cancer treatment. Clin Pharmacol Ther 2006; 80: 61-74. (Pubitemid 43946844)
-
(2006)
Clinical Pharmacology and Therapeutics
, vol.80
, Issue.1
, pp. 61-74
-
-
Borges, S.1
Desta, Z.2
Li, L.3
Skaar, T.C.4
Ward, B.A.5
Nguyen, A.6
Jin, Y.7
Storniolo, A.M.8
Nikoloff, D.M.9
Wu, L.10
Hillman, G.11
Hayes, D.F.12
Stearns, V.13
Flockhart, D.A.14
-
29
-
-
0030887069
-
Different effects of inhibitors on the O- and N-demethylation of codeine in human liver microsomes
-
DOI 10.1007/s002280050247
-
Yue QY, Säwe J: Different effects of inhibitors on the O-And N-demethylation of codeine in human liver microsomes. Eur J Clin Pharmacol 1997; 52: 41-47. (Pubitemid 27168210)
-
(1997)
European Journal of Clinical Pharmacology
, vol.52
, Issue.1
, pp. 41-47
-
-
Yue, Q.Y.1
Sawe, J.2
-
30
-
-
18544367973
-
Inhibitory effects of tricyclic antidepressants (TCAs) on human cytochrome p450 enzymes in vitro: Mechanism of drug interaction between TCAs and phenytoin
-
Shin JG, Parks JY, Kim MJ, Shon JH, Yoo YR, Cha IJ, et al: Inhibitory effects of tricyclic antidepressants (TCAs) on human cytochrome p450 enzymes in vitro: Mechanism of drug interaction between TCAs and phenytoin. Drug Metab Dispos 2002; 30: 1102-1107.
-
(2002)
Drug Metab Dispos
, vol.30
, pp. 1102-1107
-
-
Shin, J.G.1
Parks, J.Y.2
Kim, M.J.3
Shon, J.H.4
Yoo, Y.R.5
Cha, I.J.6
-
32
-
-
13444278490
-
Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: An in vitro study
-
DOI 10.1124/dmd.104.002428
-
Obach RS, Cox LM, Tremaine LM: Sertraline is metabolized by multiple cytochrome P450 enzymes monoamine oxidases, and glucuronyl transferases in human: An in vitro study. Drug metabolism and disposition. Drug Metab Dispos 2005; 33: 262-270. (Pubitemid 40216594)
-
(2005)
Drug Metabolism and Disposition
, vol.33
, Issue.2
, pp. 262-270
-
-
Obach, R.S.1
Cox, L.M.2
Tremaine, L.M.3
-
33
-
-
34248525832
-
Examination of drug-drug interaction of milnacipran hydrochloride in the presence of human P-450
-
Kazuhisa T, Kazuyuki T, Katsuya O, Satoko K, Noriaki S, Yasufumi S: Examination of drug-drug interaction of milnacipran hydrochloride in the presence of human P-450. Iyakuhin Kenkyu 2000; 31: 659-667.
-
(2000)
Iyakuhin Kenkyu
, vol.31
, pp. 659-667
-
-
Kazuhisa, T.1
Kazuyuki, T.2
Katsuya, O.3
Satoko, K.4
Noriaki, S.5
Yasufumi, S.6
-
34
-
-
24344447705
-
Lack of interaction of milnacipran with the cytochrome P450 isoenzymes frequently involved in the metabolism of antidepressants
-
DOI 10.2165/00003088-200544090-00007
-
Puozzo C, Lens S, Reh C, Michaelis K, Rosillon D, Deroubais X, et al: Lack of interaction of milnacipran with the cytochrome P450 isoenzymes frequently involved in the metabolism of antidepressants. Clin Pharmacokinet 2005; 44: 977-988. (Pubitemid 41252846)
-
(2005)
Clinical Pharmacokinetics
, vol.44
, Issue.9
, pp. 977-988
-
-
Puozzo, C.1
Lens, S.2
Reh, C.3
Michaelis, K.4
Rosillon, D.5
Deroubaix, X.6
Deprez, D.7
-
36
-
-
84855469089
-
-
Potential Interactions between Antineoplastics and Antiretrovirals ( accessed May 9 2011
-
Tony A, Tseng A: Potential Interactions between Antineoplastics and Antiretrovirals. 2011. www.hivclinic.ca/main/drugs-interact-files/Chemo-int.pdf (accessed May 9, 2011).
-
(2011)
-
-
Tony, A.1
Tseng, A.2
|